Ibalizumab (Anti-CD4)
Ibalizumab (Anti-CD4) is a humanised IgG4 monoclonal antibody, targeting C4. It prevents HIV cell entry by binding to CD4 receptor. Ibalizumab has the potential for HIV-1 infection research. MW:145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2556 |
| Sku # | A2556-1mg*25 |
| Pricing | 1mg*25, $11370.00 |